{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibd6dpjiptxet6x5aanfyzdld4mwdeho6eawmqnajtv2buctywpc4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnfx5dog2tz2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiectwry4n2a6i4hs4dkglbayxwvxouhnhgtfer46qgslgs4jbyyi4"
    },
    "mimeType": "image/jpeg",
    "size": 281736
  },
  "path": "/news/2026-06-ai-cancer-drug-revealing-lab.html",
  "publishedAt": "2026-06-03T15:00:05.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a cancer-related protein that could open the door toward the development of a new generation of more precise cancer drugs. The finding also reveals important limitations in today's artificial intelligence tools for drug discovery.",
  "title": "AI misses cancer drug target, revealing why lab validation still matters"
}